June’s top news stories

AstraZeneca reports positive results from CASPIAN trial of Imfinzi AstraZeneca’s human monoclonal antibody Imfinzi (durvalumab) improved overall survival in the…

May’s top news stories

Novartis reports positive results from Phase III trial in asthma Novartis reported that the first clinical trial in its Phase…

April’s top news stories

I-Mab and MorphoSys begin Phase III study of blood cancer drug Chinese clinical-stage biopharmaceutical company I-Mab Biopharma and German biotech…

View More